<i>drp2b</i> shows increased ROS and decreased <i>PR1</i> mRNA to living <i>Pto</i> in a T3SS-independent manner. by John M. Smith (676719)

Disruption of poly-ADP-ribosylation decreases nucleolar CTCF, disrupts nucleolar structure, and increases <i>rDNA</i> expression. by Paola A. Guerrero (357587)

Analysis of AMPA-R mediated EPSCs (aEPSCs) at CA1 synapses in hippocampal slices from P10 mice ICV injected at P1, P3, and P5 with saline or GR1. by Nicole M. Lykens (3727072)

“…<b>(d)</b> Rectification index of aEPSC amplitude was moderately decreased after SMO treatment (n = 8; p = 0.017). …”

Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

“…Data are presented as mean ± SEM; *, p<0.05, **, p<0.01, ***, p<0.01, Student's t-test.…”

Hsp90 interacts with BMS1 and decreased Hsp90 function compromises 80S ribosome and polysome stability at 16°C. by Eric A. Franzosa (130063)

Image_5_Requirement of a putative mitochondrial GTPase, GemA, for azole susceptibility, virulence, and cell wall integrity in Aspergillus fumigatus.JPEG by Xiaogang Zhou (3115482)

Flow cytometry analysis of Annexin V/FITC-PI on SW480 and HCT116 cells treated with negative control, THC, βCD-THC inclusion complex, and camptothecin. by Zhi Xuan Low (19270163)

Citrulline as a nutraceutical protects against eCM. by Irene Gramaglia (6439613)

Decreased branching, partial right isomerization and epithelial proximalization in CKO lungs. by Stijn P. De Langhe (38981)

“…<p>(a–d) β-gal staining of <i>Dermo1^Cre/+/Rosa26R</i> WT lungs at E11.5 and E13.5 reports Cre recombination activity in the mesenchyme of the embryonic lung. …”

SEM images of the samples (a) virgin sample (b) 0.4 wt. % <i>f-MWCNTs</i> (c) 0.5 wt. % <i>f—MWCNTs</i>. by Shaban Gul (14309526)

Local inhibition of nitrergic activity in tenotomized rats accelerates muscle regeneration by increasing fiber area and decreasing central core lesions by A.D. Seabra (6515330)

“…<div><p>Muscular atrophy is a progressive degeneration characterized by muscular proteolysis, loss of mass and decrease in fiber area. …”

Decreased temperature dampens pERK2 difference in spinal cord. by Katelyn E. Sadler (480365)

Bcl-x_L decreases ionomycin-induced MIMP. by Daniel Tornero (218854)

<i>abo8</i> mutation decreases the activity of the root meristem. by Li Yang (6520)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”

Ciliated prostate cancer and stromal cells have decreased axoneme lengths. by Nadia B. Hassounah (429199)

P63 and CD44 expression were decreased in triple mutants. by Kyung-Suk Choi (162073)

“…Np63 was expressed in the AER and epithelial cells of E10.5 and E11.5 control (A and C) and triple mutant hindlimbs (B and D). …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”